Colon signet ring cell adenocarcinoma: Immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas

被引:49
作者
Goldstein, NS
Long, A
Kuan, SF
Hart, J
机构
[1] William Beaumont Hosp, Dept Pathol, Royal Oak, MI 48073 USA
[2] Univ Chicago Hosp, Chicago, IL 60637 USA
来源
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 2000年 / 8卷 / 03期
关键词
colon; stomach; adenocarcinoma; signet ring cell; glandular immunohistochemistry; cytokeratin; 7; 20; 17; 19; CA; 125; 19-9; biopsy; metastasis;
D O I
10.1097/00022744-200009000-00003
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Colon signet ring cell adenocarcinomas are uncommon, high-grade neoplasms. Given their rarity, the question of primary colon or metastatic gastric adenocarcinoma frequently arises when signet ring cell carcinoma is seen in a colonoscopic biopsy or in biopsies procured from other regions of the body. A second related question regarding colon and gastric signet ring cell carcinomas is their immunophenotypic similarities with the glandular form of adenocarcinoma in each site. We studied the immunohistochemical phenotype of 14 colonic signet ring cell adenocarcinomas and compared them with immunophenotype of 27 gastric signet ring cell adenocarcinomas. We also compared the immunophenotype of the 27 gastric signet ring cell with the immunophenotype of 19 gastric gland-forming adenocarcinomas, and the immunophenotype of the 14 colonic signet ring cell adenocarcinomas to the immunophenotype of 20 colonic gland-forming adenocarcinomas to identify staining differences in the neoplastic cells of the two architectures. Antibodies studied were cytokeratins 7, 17, 19, and 20, CA 19-9, CA-125, estrogen receptor, and gross cystic disease fluid protein 15. Sixty-four percent of colon signet ring cell adenocarcinomas had either no staining or focal staining with cytokeratin 7 compared with diffuse staining in 63% of gastric signet ring cell adenocarcinomas (P = 0.016). Seventy-two percent of colon signet ring cell adenocarcinomas had diffuse staining with cytokeratin 20 compared with no or focal staining in 50% of gastric signet ring cell adenocarcinomas (P = 0.019). Fifty-seven percent of the colon signet ring cell adenocarcinomas had a cytokeratin 7 (-)/cytokeratin 20 (+) staining pattern compared with 11% of gastric signet ring cell adenocarcinomas (P = 0.004). Forty-four percent of gastric signet ring cell adenocarcinomas had a cytokeratin 7 (+)/cytokeratin 20 (-) pattern, compared with none of the colon signet ring cell adenocarcinomas (P = 0.004). The staining distribution of the antibody battery was similar in colon signet ring cell and colon glandular adenocarcinoma and gastric signer ring cell and gastric glandular adenocarcinomas. When signet ring cell adenocarcinoma is encountered in a colon biopsy, a colon primary is supported if the neoplastic cells have a cytokeratin 7 (-)/cytokeratin 20 (+) staining pattern, and a gastric primary is supported if they have a cytokeratin 7 (+)/cytokeratin 20 (-) staining pattern. The signet ring morphology at each site had an identical immunophenotype as the cells forming their glandular counterpart.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 19 条
[1]   THE APPLICABILITY OF A KERATIN 7 MONOCLONAL-ANTIBODY IN ROUTINELY PAPANICOLAOU-STAINED CYTOLOGIC SPECIMENS FOR THE DIFFERENTIAL-DIAGNOSIS OF CARCINOMAS [J].
BAARS, JH ;
DERUIJTER, JLM ;
SMEDTS, F ;
VANNIEKERK, CC ;
POELS, LG ;
SELDENRIJK, CA ;
RAMAEKERS, FCS .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 101 (03) :257-261
[2]  
Berezowski K, 1996, MODERN PATHOL, V9, P426
[3]  
FUJISAKI J, 1993, GASTROENTEROL JPN, V28, P647
[4]   Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites [J].
Kaufmann, O ;
Deidesheimer, T ;
Muehlenberg, M ;
Deicke, P ;
Dietel, M .
HISTOPATHOLOGY, 1996, 29 (03) :233-240
[5]   Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites [J].
Lagendijk, JH ;
Mullink, H ;
Van Diest, PJ ;
Meijer, GA ;
Meijer, CJLM .
HUMAN PATHOLOGY, 1998, 29 (05) :491-497
[6]  
Loy TS, 1996, MODERN PATHOL, V9, P1040
[7]   UTILITY OF CYTOKERATIN IMMUNOSTAINING IN SEPARATING PULMONARY ADENOCARCINOMAS FROM COLONIC ADENOCARCINOMAS [J].
LOY, TS ;
CALALUCE, RD .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (06) :764-767
[8]  
Maeda T, 1996, MODERN PATHOL, V9, P901
[9]   Keratin 17 - Immunohistochemical mapping of its distribution in human epithelial tumors and its potential applications [J].
Miettinen, M ;
Nobel, MP ;
Tuma, BT ;
Kovatich, AJ .
APPLIED IMMUNOHISTOCHEMISTRY, 1997, 5 (03) :152-159
[10]  
MIETTINEN M, 1995, MODERN PATHOL, V8, P384